HUBUNGAN LAMA WAKTU PASCA KEMORADIASI DENGAN DERAJAT DISFAGIA OROFARINGEAL PADA KARSINOMA NASOFARING
DOI:
https://doi.org/10.36408/mhjcm.v8i1.400Abstract
Abstract
Background : Dysphagia can occur as a side effect in patients with nasopharyngeal carcinoma (NPC) receiving chemoradiation therapy. The reported incidence rate up to 83%. The degree of oropharyngeal dysphagia accosiated with the long time of post-chemoradiation in NPC is not yet clearly known. Objective : To analysis the degree of oropharyngeal dysphagia accosiated with the long time of post-chemoradiation in NPC. Method : Analysis observational research with cross sectional design. The subjects were patients with post-chemoradiation NPC at RSUP Dr. Kariadi Semarang who met the inclusion criteria. Determination of dysphagia status and degree of dysphagia by Gugging Swallowing Screen (GUSS). The complete details of the subjects were obtained from history and medical records. Chi-Squared is used for the statistical test. Outcome : Fifty five (100%) subjects had dysphagia, 48 (87.3%) subjects had mild degrees of dysphagia, no subjects with moderate degree of dysphagia were found, and 7 (12.7%) subjects had severe dysphagia. Long time of post-chemoradiation (p = 0.451), type of chemotherapy (p = 0.267), and therapeutic modality (p = 0.402) were not related to the degree of oropharyngeal dysphagia in NPC. Conclusion : The majority of subjects had mild degree dysphagia. Long time of post-chemoradiation, type of chemotherapy, and modality of therapy are not related to the degree of oropharyngeal dysphagia in NPC.
Keywords: NPC, chemoradiation, degree of dysphagia, GUSS.
Downloads
References
Smith LJ. Upper digestive tract anatomy and physiology. In: Johnson J, Rosen C, editors. Bailey's head and neck surgery - otolaryngology. Fifth ed. Philadelphia: Lippincott Williams and Wilkins; 2014. p. 817-24.
Nguyen NP, Frank C, Moltz CC, Vos P, Smith HJ, Karlsson U, et al. Impact of dysphagia on quality of life after treatment of head and neck cancer. International Journal of Radiation Oncology Biology Physics. 2005;61(3):772-8.
Logemann JA, Rademaker AW, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B, et al. Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head and Neck: Journal for the Sciences and Specialties of the Head and Neck. 2006;28(1):64-73.
Koiwai K, Shikama N, Sasaki S, Shinoda A, Kadoya M. Risk factors for severe dysphagia after concurrent chemoradiotherapy for head and neck cancers. Japanese Journal of Clinical Oncology. 2009;39(7):413-7.
Patterson JM, Hildreth A, McColl E, Carding PN, Hamilton D, Wilson JA. The clinical application of the 100 mL water swallow test in head and neck cancer. Oral oncology. 2011;47(3):180-4.
Trapl M, Enderle P, Nowotny M, Teuschl Y, Matz K, Dachenhausen A, et al. Dysphagia bedside screening for acute stroke patients: the Gugging Swallowing Screen (GUSS). Stroke. 2007;38(11):2948-52.
Warnecke T, Im S, Kaiser C, Hamacher C, Oelenberg S, Dziewas R. Aspiration and dysphagia screening in acute stroke–the Gugging Swallowing Screen (GUSS) revisited. European Journal of Neurology. 2017;24(4):594-601.
Nguyen N, Moltz C, Frank C, Vos P, Smith H, Karlsson U, et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Annals of Oncology. 2004;15(3):383-8.
Goguen LA, Posner MR, Norris CM, Tishler RB, Wirth LJ, Annino DJ, et al. Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngology - Head and Neck Surgery. 2006;134(6):916-22.
Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. Journal of Clinical Oncology. 2008;26(21):3582.
Chang YC, Chen SY, Lui LT, Wang TG, Wang TC, Hsiao TY, et al. Dysphagia in patients with nasopharyngeal cancer after radiation therapy: a videofluoroscopic swallowing study. Dysphagia. 2003;18(2):135-43.
Langendijk J, Leemans CR, Buter J, Berkhof J, Slotman B. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. Journal of Clinical Oncology. 2004;22(22):4604-12.
Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, et al. NCCN guidelines insights: head and neck cancers, version 2.2017. Journal of the National Comprehensive Cancer Network. 2017;15(6):761-70.
Tse K, Wong H, Au E, Ma K. Chemotherapy for primary treatment of locoregionally advanced nasopharyngeal carcinoma: update on meta-analyses and phase III trials. Journal-Hong Kong College of Radiologists. 2005;8(2):93.
Wiliyanto O. Insidensi kanker kepala leher berdasarkan diagnosis patologi anatomi di RS DR Kariadi Semarang periode 1 Januari 2001–31 Desember 2005: Faculty of Medicine; 2006.
Johnson S, Corsten M, McDonald J, Chun J. Socio-economic factors and stage at presentation of head and neck cancer patients in Ottawa, Canada: A logistic regression analysis. Oral oncology. 2010;46(5):366-8.
Teguh DN, Levendag PC, Noever I, van Rooij P, Voet P, van der Est H, et al. Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx. International Journal of Radiation Oncology Biology Physics. 2008;72(4):1119-27.
Wilson JA, Carding PN, Patterson JM. Dysphagia after nonsurgical head and neck cancer treatment: patients’ perspectives. Otolaryngology - Head and Neck Surgery. 2011;145(5):767-71.
Kaur P, Pannu A, Singh S. Assessment of swallowing and neck dysfunction post radiotherapy/chemo-radiotherapy in head and neck cancer patients. Biom Biostat Int J. 2016;3(3):00066.
Nguyen NP,Vos P, Molzt C, Frank C, Millar C, Smith H et al. Analysis of the factors influencing dysphagia severity upon diagnosis of head neck cancer. The British Journal of Radiology.2008:81(969):706-10
Nguyen NP, Sallah S, Karlsson U, Antoine JE. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer. 2002;94(4):1131-41.
Kartikawati H. Preparat anti jamur dalam pencegahan mukositis oral akibat efek samping radioterapi pada pasien keganasan kepala leher. Media Medika Indonesiana. 2011;45(3):163-8.
King SN, Dunlap NE, Tennant PA, Pitts T. Pathophysiology of radiation-induced dysphagia in head and neck cancer. Dysphagia. 2016;31(3):339-51.
Logemann JA, Pauloski BR, Rademaker AW, Lazarus CL, Gaziano J, Stachowiak L, et al. Swallowing disorders in the first year after radiation and chemoradiation. Head and Neck: Journal for the Sciences and Specialties of the Head and Neck. 2008;30(2):148-58.
Fitriatuzzakiyyah N, Sinuraya RK, Puspitasari IM, Farmakologi D, Farmasi F. Terapi kanker dengan radiasi: konsep dasar radioterapi dan perkembangannya di Indonesia. Indonesian Journal of Clinical Pharmacy. 2017;6(4):311-20.
Surjadi N, Amtha R. Radiotherapy reduced salivary flow rate and might induced C. albicans infection. Journal of Dentistry Indonesia. 2013;19(1):14-9.
Gaziano JE. Evaluation and management of oropharyngeal dysphagia in head and neck cancer. Cancer control. 2002;9(5):400-9.
Patterson JM, Owen S. Dysphagia following radical chemoradiotherapy treatment for HNSCC. The Otorhinolaryngologist. 2013;6(2):104–10.
Otty Z, Skinner MB, Dass J, Collins M, Mooi J, Thuraisingam K, et al. Efficacy and tolerability of weekly low?dose cisplatin concurrent with radiotherapy in head and neck cancer patients. Asia?Pacific Journal of Clinical Oncology. 2011;7(3):287-92.
Eisbruch A, Lyden T, Bradford CR, Dawson LA, Haxer MJ, Miller AE, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head and neck cancer. International Journal of Radiation Oncology Biology Physics. 2002;53(1):23-8.
Hutcheson KA, Lewin JS, Holsinger FC, Steinhaus G, Lisec A, Barringer DA, et al. Long?term functional and survival outcomes after induction chemotherapy and risk?based definitive therapy for locally advanced squamous cell carcinoma of the head and neck. Head and Neck. 2014;36(4):474-80.
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2021 Medica Hospitalia : Journal of Clinical Medicine
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
